The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...

Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...

Kardium Inc., an emerging leader in advanced solutions for atrial fibrillation, is proud to announce the publication of the ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ ...

Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...

Non-invasive cardiac mapping reconstructed 3D cardiac activation and improved arrhythmia localisation. Read more about its clinical potential.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Trinity Health Livonia has announced the expansion of its cardiovascular services to include advanced left-sided cardiac ablation procedures.

Minneapolis-based Imricor Medical Systems said it won 510(k) clearance from the FDA for its Vision-MR Diagnostic Catheter.

A new study has demonstrated that non-invasive cardiac mapping can accurately reconstruct three-dimensional electrical activity of the heart, offering a safer and more precise method to locate complex ...

Medtronic plc is rated a Buy with solid growth prospects, balance sheet remains A-rated and shares are undervalued. Learn ...